Literature DB >> 9620659

Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor.

S Adam-Klages1, R Schwandner, D Adam, D Kreder, K Bernardo, M Krönke.   

Abstract

Ceramide, generated by the enzymatic function of sphingomyelinases (SMases) has emerged as an important signaling pathway transducing diverse biological effects of various cytokine receptors. The 55-kDa receptor for tumor necrosis factor (TNF-R55) activates two types of SMases through distinct cytoplasmic domains. The death domain that is responsible for the initiation of the apoptotic pathway also signals for the activation of an acid SMase (A-SMase). The adapter protein TRADD binds to TNF-R55 in a ligand-dependent manner and serves as anchor for the subsequent recruitment of other proteins into the signaling complex that directly lead to cell death or nuclear factor-kappaB (NF-kappaB) induction. Notably, the two pro-apoptotic adapter proteins TRADD and FADD are also involved in the activation of A-SMase. In contrast, the NF-kappaB-inducing adapters TRAF2 and RIP do not signal for A-SMase. Thus, activation of A-SMase appears to belong to signals leading to TNF-induced cell death. A second signaling domain (NSD) is located upstream of the death domain and directly links the TNF-R55 to the activation of a neutral SMase (N-SMase). A novel adapter protein, FAN, has been identified that specifically binds to the NSD. FAN contains five WD repeats at its carboxy terminus, while it shows significant sequence homology with the mouse beige protein and its human homolog, the CHS protein, in the center portion of the protein. Overexpression of full-length FAN enhanced N-SMase activity in TNF-treated cells, whereas truncated mutants of FAN produced dominant negative effects. FAN, however, did not interfere with any of the TNF responses signaled for by the death domain. Taken together, our data suggest that distinct cytoplasmic domains of TNF-R55 initiate independent signaling pathways by binding different adapter proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620659     DOI: 10.1002/jlb.63.6.678

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  21 in total

Review 1.  Control of apoptosis of cardiovascular fibroblasts: a novel drug target.

Authors:  H Rupp; B Maisch
Journal:  Herz       Date:  1999-05       Impact factor: 1.443

Review 2.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

3.  Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice.

Authors:  Rose-Marie Bluthé; Keith W Kelley; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2006-01       Impact factor: 7.217

4.  Tumor necrosis factor alpha activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary cultures of neurons.

Authors:  G Barbin; M P Roisin; B Zalc
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

5.  Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons.

Authors:  Elizabeth J Bowen; Thomas W Schmidt; Christina S Firm; Andrew F Russo; Paul L Durham
Journal:  J Neurochem       Date:  2005-11-08       Impact factor: 5.372

Review 6.  Shared pathways: death receptors and cytotoxic drugs in cancer therapy.

Authors:  I Peták; J A Houghton
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 7.  Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease.

Authors:  Michael B Reid; Jennifer S Moylan
Journal:  J Physiol       Date:  2011-02-14       Impact factor: 5.182

8.  PtdIns(4,5)P-restricted plasma membrane localization of FAN is involved in TNF-induced actin reorganization.

Authors:  Dirk Haubert; Nina Gharib; Francisco Rivero; Katja Wiegmann; Marianna Hösel; Martin Krönke; Hamid Kashkar
Journal:  EMBO J       Date:  2007-06-28       Impact factor: 11.598

9.  Tumor necrosis factor inhibits ligand-stimulated EGF receptor activation through a TNF receptor 1-dependent mechanism.

Authors:  Steven J McElroy; Mark R Frey; Fang Yan; Karen L Edelblum; Jeremy A Goettel; Sutha John; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-08       Impact factor: 4.052

10.  Ceramide inhibits CCN2 expression in fibroblasts.

Authors:  Laura Kennedy; Sunil Parapuram; Jill Greenspoon; Andrew Leask
Journal:  J Cell Commun Signal       Date:  2008-07-23       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.